CMBFX | ORTYX | CMBFX / ORTYX | |
Total Expense Ratio | 0.56 | 0.55 | 102% |
Annual Report Gross Expense Ratio | 0.60 | 0.55 | 109% |
Fund Existence | 41 years | 29 years | - |
Gain YTD | 0.157 | -0.603 | -26% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 287M | 279M | 103% |
Annual Yield % from dividends | 2.46 | 3.13 | 79% |
Returns for 1 year | 1.40 | 0.51 | 276% |
Returns for 3 years | 6.67 | 5.07 | 132% |
Returns for 5 years | 0.69 | -2.14 | -32% |
Returns for 10 years | 14.72 | 11.00 | 134% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBDS | 24.14 | -0.01 | -0.04% |
iShares iBonds Dec 2027 Term Corp ETF | |||
FXZ | 56.33 | -0.28 | -0.49% |
First Trust Materials AlphaDEX® ETF | |||
IGTR | 23.80 | -0.29 | -1.20% |
Innovator Gradient Tactical Rot Str ETF | |||
SEIV | 34.15 | -0.45 | -1.31% |
SEI Enhanced US Large Cap Value Fac ETF | |||
UGE | 18.52 | -0.41 | -2.15% |
ProShares Ultra Consumer Staples |